Ātra kopsavilkums

Zāļu veids

Dual GIP and GLP-1 receptor agonist.

Darbojas, izmantojot

Control blood sugar levels and reduce appetite.

Aktīvā viela

Tirzepatide

Efektīvs laikā

Within a few weeks.

Generisks?

No

Blakusparādības

Nausea, vomiting, diarrhea, decreased hunger, stomach pain, and constipation.

Jūsu stāsti, mūsu lepnums

Zāļu informācija

Apraksts

Mounjaro® (Tirzepatide) ir progresīva svara kontroles ārstēšana, kas imitē divus dabiskos hormonus jūsu ķermenī: GLP-1 un GIP. Darbojoties uz šiem diviem atsevišķiem signāliem vienlaikus, tas palīdz efektīvāk regulēt jūsu apetīti nekā ārstēšanas, kas izmanto tikai vienu. Šī unikālā dubultā darbība palīdz jums justies pilnīgākam ilgāk un nomāc ēdiena kāres, padarot vieglāku veselīgāku rutīnu ievērošanu.

Izstrādāts vienkāršībai, Mounjaro ir ērts daudzdevu pildspalvas veidā. Katrs pildspalva satur 4 nedēļas devas (pilnu mēneša devu) un ietver adatas, padarot jūsu ārstēšanas plānu viegli pārvaldāmu.

Lietošanas norādījumi

Once a week one injection.

Sastāvdaļas

Active Ingredient Tirzepatide Each pre-filled pen contains 0.5 ml of solution. The medication is available in the following strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Other Ingredients (Excipients) Disodium hydrogen phosphate heptahydrate (E339) Sodium chloride Sodium hydroxide (for pH adjustment) Concentrated hydrochloric acid (for pH adjustment) Water for injections

Blakusparādības

Gastrointestinal problems (nausea, vomiting, diarrhoea, constipation), a potential risk of hypoglycaemia (especially when used with other diabetes medications), injection site reactions, and other effects depending on the individual’s health status and other medicines taken.

Brīdinājumi

When using Mounjaro (tirzepatide), it is important to take certain precautions. Be alert to severe abdominal pain, which may indicate pancreatitis. Monitor blood sugar levels closely, as there is a risk of hypoglycaemia when Mounjaro is used together with other diabetes medications. Report any changes in urination, which could signal kidney problems, and seek medical advice promptly if you experience persistent digestive symptoms such as vomiting or diarrhoea.

It is also essential to inform your doctor of any personal or family history of thyroid cancer, as studies in rodents have linked medicines similar to Mounjaro to thyroid-related issues. Watch for signs of allergic reactions, and if you are pregnant or breastfeeding, consult your healthcare professional about potential risks before using this medication.

Biežāk uzdotie jautājumi

What is the difference between Mounjaro and Wegovy?How quickly does Mounjaro start to work?

Both medications are effective injectable treatments for weight management, but they work in slightly different ways.

Wegovy (Semaglutide) mimics one natural hormone called GLP-1. It primarily focuses on regulating appetite and slowing down digestion to help you feel full.

Mounjaro (Tirzepatide) is a newer treatment that mimics two hormones: GLP-1 and GIP. By targeting both signals at the same time, Mounjaro acts on improved appetite control and metabolic regulation. Clinical studies suggest that this "dual action" may lead to greater weight loss results for some patients compared to treatments that target only one hormone.

How quickly does Mounjaro start to work?

The onset of Mounjaro's effects can vary, but patients may begin to see improvements in their blood sugar levels and weight within a few weeks of starting treatment. Continuous use in conjunction with diet and exercise enhances its efficacy.

How is Mounjaro administered?

Mounjaro is administered as a subcutaneous injection once a week. It can be injected into the abdomen, thigh, or upper arm, with the site of injection rotated each week to minimise the risk of skin irritation.

How should Mounjaro be stored?

Mounjaro should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Keep the pen in its original packaging to protect from light. Once in use, it may be kept at room temperature for 30 days.

Do I need a prescription for Mounjaro?

Yes, Mounjaro is a prescription medication. You will need to consult a healthcare provider to determine if it's appropriate for your condition and to receive a prescription. Using our online consultation service will enable you to answer a short questionnaire that would be used by one of our clinical prescribers to determine your eligibility for the treatment and approve or decline and refund your order.

Neatradāt savu atbildi?

Jūtieties brīvi sazināties ar mums